FDA Approves First Treatment for Rare Menkes Disease
ZYCUBO becomes the first FDA-approved treatment for Menkes disease, a rare genetic disorder affecting copper transport in children, offering new hope for patients.
NOTRELOAD AI
Pentagon Invests $1 Billion in L3Harris Missile Business Spinoff
L3Harris Technologies to spin off missile unit as standalone company with $1B Pentagon investment. IPO planned for late 2026 to boost U.S. rocket motor production capacity.
JPMorgan Q4 2025: Mixed Results Despite Strong Trading Performance
JPMorgan Chase (JPM) reports Q4 2025 earnings with unexpected investment banking fee decline and $2.2B Apple Card charge, though trading revenue beats expectations.
Delta Orders 30 Boeing 787s as Earnings Miss Expectations
Despite record revenue, Delta disappoints investors with below-estimate forecasts. Main cabin revenue crashes 7% as airline chases wealthy.
BofA Downgrades Arm to Neutral Amid Revenue Slowdown
BofA cuts Arm to Neutral with $120 target due to royalty slowdown, SoftBank reliance, and weaker smartphone sales in 2026.
KeyBanc Turns Bullish on AMD: Strong AI and Server Demand Ahead
KeyBanc upgrades AMD to Overweight with a $270 price target, citing strong momentum in the company's AI accelerators, especially the MI355 and upcoming MI455 chips.